Radiopharmaceuticals in Nuclear Medicine Market Report

Global and Regional Radiopharmaceuticals in Nuclear Medicine Market Details Research Report 2021-2026

  • POSTDATE：Jun 26, 2021
  • PAGES：190
  • REPORT CODE：GMM727436
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Radiopharmaceuticals in Nuclear Medicine Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Radiopharmaceuticals in Nuclear Medicine market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Radiopharmaceuticals in Nuclear Medicine market.

    By Player:

    • Covidien, Plc

    • Urenco Limited

    • Institute of Isotopes Co Ltd

    • Cambridge Isotope Laboratories Inc

    • Lantheus Medical Imaging Inc

    • Board of Radiation And Isotope Technology (BRIT)

    • Institute of Atomic Energy Polatom Radioisotope Centre

    • Ntp Radioisotopes (Pty) Ltd

    • Nordion Inc

    • Rotem Industries Ltd Inc

    • GE Healthcare (Subsidiary Of General Electric Company)

    • Isotec Inc (Sigma-Aldrich)

    • Taiyo Nippon Sanso Corporation

    • Fujifilm Holdings Corporation

    • Australian Nuclear Association And Technology Organization (ANSTO)

    • Cardinal Health Inc

    • Siemens Healthcare (Subsidiary Of Siemens AG)

    • Bracco Imaging SPA

    • IBA Group

    • Eczacibasi-Monrol

    • Institute Of Radioelement (IRE)

    By Type:

    • Diagnostic Radiopharmaceuticals

    • Therapy Radiopharmaceuticals

    • Enriched Stable Isotopes

    By End-User:

    • Diagnostic Application

    • Therapeutic Application

    • Research

    • Pharmaceutical

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Radiopharmaceuticals in Nuclear Medicine Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Radiopharmaceuticals in Nuclear Medicine Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Covidien, Plc

      • 3.1.1 Covidien, Plc - Company Business Overview

      • 3.1.2 Covidien, Plc - Company Financial Performance

      • 3.1.3 Covidien, Plc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.1.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Urenco Limited

      • 3.2.1 Urenco Limited - Company Business Overview

      • 3.2.2 Urenco Limited - Company Financial Performance

      • 3.2.3 Urenco Limited - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.2.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Institute of Isotopes Co Ltd

      • 3.3.1 Institute of Isotopes Co Ltd - Company Business Overview

      • 3.3.2 Institute of Isotopes Co Ltd - Company Financial Performance

      • 3.3.3 Institute of Isotopes Co Ltd - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.3.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Cambridge Isotope Laboratories Inc

      • 3.4.1 Cambridge Isotope Laboratories Inc - Company Business Overview

      • 3.4.2 Cambridge Isotope Laboratories Inc - Company Financial Performance

      • 3.4.3 Cambridge Isotope Laboratories Inc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.4.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Lantheus Medical Imaging Inc

      • 3.5.1 Lantheus Medical Imaging Inc - Company Business Overview

      • 3.5.2 Lantheus Medical Imaging Inc - Company Financial Performance

      • 3.5.3 Lantheus Medical Imaging Inc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.5.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Board of Radiation And Isotope Technology (BRIT)

      • 3.6.1 Board of Radiation And Isotope Technology (BRIT) - Company Business Overview

      • 3.6.2 Board of Radiation And Isotope Technology (BRIT) - Company Financial Performance

      • 3.6.3 Board of Radiation And Isotope Technology (BRIT) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.6.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Institute of Atomic Energy Polatom Radioisotope Centre

      • 3.7.1 Institute of Atomic Energy Polatom Radioisotope Centre - Company Business Overview

      • 3.7.2 Institute of Atomic Energy Polatom Radioisotope Centre - Company Financial Performance

      • 3.7.3 Institute of Atomic Energy Polatom Radioisotope Centre - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.7.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Ntp Radioisotopes (Pty) Ltd

      • 3.8.1 Ntp Radioisotopes (Pty) Ltd - Company Business Overview

      • 3.8.2 Ntp Radioisotopes (Pty) Ltd - Company Financial Performance

      • 3.8.3 Ntp Radioisotopes (Pty) Ltd - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.8.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Nordion Inc

      • 3.9.1 Nordion Inc - Company Business Overview

      • 3.9.2 Nordion Inc - Company Financial Performance

      • 3.9.3 Nordion Inc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.9.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Rotem Industries Ltd Inc

      • 3.10.1 Rotem Industries Ltd Inc - Company Business Overview

      • 3.10.2 Rotem Industries Ltd Inc - Company Financial Performance

      • 3.10.3 Rotem Industries Ltd Inc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.10.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 GE Healthcare (Subsidiary Of General Electric Company)

      • 3.11.1 GE Healthcare (Subsidiary Of General Electric Company) - Company Business Overview

      • 3.11.2 GE Healthcare (Subsidiary Of General Electric Company) - Company Financial Performance

      • 3.11.3 GE Healthcare (Subsidiary Of General Electric Company) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.11.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Isotec Inc (Sigma-Aldrich)

      • 3.12.1 Isotec Inc (Sigma-Aldrich) - Company Business Overview

      • 3.12.2 Isotec Inc (Sigma-Aldrich) - Company Financial Performance

      • 3.12.3 Isotec Inc (Sigma-Aldrich) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.12.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Taiyo Nippon Sanso Corporation

      • 3.13.1 Taiyo Nippon Sanso Corporation - Company Business Overview

      • 3.13.2 Taiyo Nippon Sanso Corporation - Company Financial Performance

      • 3.13.3 Taiyo Nippon Sanso Corporation - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.13.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Fujifilm Holdings Corporation

      • 3.14.1 Fujifilm Holdings Corporation - Company Business Overview

      • 3.14.2 Fujifilm Holdings Corporation - Company Financial Performance

      • 3.14.3 Fujifilm Holdings Corporation - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.14.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Australian Nuclear Association And Technology Organization (ANSTO)

      • 3.15.1 Australian Nuclear Association And Technology Organization (ANSTO) - Company Business Overview

      • 3.15.2 Australian Nuclear Association And Technology Organization (ANSTO) - Company Financial Performance

      • 3.15.3 Australian Nuclear Association And Technology Organization (ANSTO) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.15.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 Cardinal Health Inc

      • 3.16.1 Cardinal Health Inc - Company Business Overview

      • 3.16.2 Cardinal Health Inc - Company Financial Performance

      • 3.16.3 Cardinal Health Inc - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.16.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 Siemens Healthcare (Subsidiary Of Siemens AG)

      • 3.17.1 Siemens Healthcare (Subsidiary Of Siemens AG) - Company Business Overview

      • 3.17.2 Siemens Healthcare (Subsidiary Of Siemens AG) - Company Financial Performance

      • 3.17.3 Siemens Healthcare (Subsidiary Of Siemens AG) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.17.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.17.5 Strategic Initiatives

    • 3.18 Bracco Imaging SPA

      • 3.18.1 Bracco Imaging SPA - Company Business Overview

      • 3.18.2 Bracco Imaging SPA - Company Financial Performance

      • 3.18.3 Bracco Imaging SPA - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.18.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.18.5 Strategic Initiatives

    • 3.19 IBA Group

      • 3.19.1 IBA Group - Company Business Overview

      • 3.19.2 IBA Group - Company Financial Performance

      • 3.19.3 IBA Group - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.19.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.19.5 Strategic Initiatives

    • 3.20 Eczacibasi-Monrol

      • 3.20.1 Eczacibasi-Monrol - Company Business Overview

      • 3.20.2 Eczacibasi-Monrol - Company Financial Performance

      • 3.20.3 Eczacibasi-Monrol - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.20.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.20.5 Strategic Initiatives

    • 3.21 Institute Of Radioelement (IRE)

      • 3.21.1 Institute Of Radioelement (IRE) - Company Business Overview

      • 3.21.2 Institute Of Radioelement (IRE) - Company Financial Performance

      • 3.21.3 Institute Of Radioelement (IRE) - Company Financial Performance of Radiopharmaceuticals in Nuclear Medicine

      • 3.21.4 Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

      • 3.21.5 Strategic Initiatives

    4 Global Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Diagnostic Radiopharmaceuticals 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Therapy Radiopharmaceuticals 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Enriched Stable Isotopes 2016-2021

    • 4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Diagnostic Radiopharmaceuticals 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Therapy Radiopharmaceuticals 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Enriched Stable Isotopes 2016-2021

    • 4.4 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Radiopharmaceuticals in Nuclear Medicine Market Price By Type from 2016 to 2026

    5 Global Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Radiopharmaceuticals in Nuclear Medicine

    • 5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Diagnostic Application 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Therapeutic Application 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Research 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Pharmaceutical 2016-2021

      • 5.2.5 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Diagnostic Application 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Therapeutic Application 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Research 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Pharmaceutical 2016-2021

      • 5.3.5 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Application (Forecast)

    6 Global Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis (Geography Level)

    • 6.1 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Radiopharmaceuticals in Nuclear Medicine Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Radiopharmaceuticals in Nuclear Medicine Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Radiopharmaceuticals in Nuclear Medicine Market from 2016 to 2020

    7. North America Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 7.1.1 North America Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 7.1.2 North America Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 7.3 North America Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 8.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 8.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 8.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 9.1.1 Asia Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 9.1.2 Asia Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 9.3 Asia Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 10.1.1 South America Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 10.1.2 South America Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 10.3 South America Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 11.1.1 Middle East Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 11.1.2 Middle East Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 11.3 Middle East Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 12.1.1 Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 12.1.2 Africa Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 12.3 Africa Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Radiopharmaceuticals in Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Radiopharmaceuticals in Nuclear Medicine Market Segment by Countries

      • 13.1.1 Oceania Radiopharmaceuticals in Nuclear Medicine Market Revenue Segment by Countries

      • 13.1.2 Oceania Radiopharmaceuticals in Nuclear Medicine Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Radiopharmaceuticals in Nuclear Medicine Market Segment (Product Type Level)

    • 13.3 Oceania Radiopharmaceuticals in Nuclear Medicine Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Radiopharmaceuticals in Nuclear Medicine Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine

      • 14.2.2 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Radiopharmaceuticals in Nuclear Medicine Industry Market Status, Pre-COVID-19

      • 15.5.3 Radiopharmaceuticals in Nuclear Medicine Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Radiopharmaceuticals in Nuclear Medicine Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Radiopharmaceuticals in Nuclear Medicine Product Picture

    • Table Radiopharmaceuticals in Nuclear Medicine Product Definition

    • Table Study Scope by Types

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Market Value by Application (2016 - 2026)

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate from 2016 to 2026

    • Table Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Manufacturers (2016-2021)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2016-2021)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Radiopharmaceuticals in Nuclear Medicine Plant Distribution and Sales Country

    • Table Covidien, Plc - Company Business Overview

    • Figure Covidien, Plc Total Revenue from 2018 to 2020

    • Table Covidien, Plc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Covidien, Plc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Covidien, Plc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Urenco Limited - Company Business Overview

    • Figure Urenco Limited Total Revenue from 2018 to 2020

    • Table Urenco Limited Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Urenco Limited Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Urenco Limited

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Institute of Isotopes Co Ltd - Company Business Overview

    • Figure Institute of Isotopes Co Ltd Total Revenue from 2018 to 2020

    • Table Institute of Isotopes Co Ltd Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Institute of Isotopes Co Ltd Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Institute of Isotopes Co Ltd

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Cambridge Isotope Laboratories Inc - Company Business Overview

    • Figure Cambridge Isotope Laboratories Inc Total Revenue from 2018 to 2020

    • Table Cambridge Isotope Laboratories Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cambridge Isotope Laboratories Inc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Cambridge Isotope Laboratories Inc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Lantheus Medical Imaging Inc - Company Business Overview

    • Figure Lantheus Medical Imaging Inc Total Revenue from 2018 to 2020

    • Table Lantheus Medical Imaging Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lantheus Medical Imaging Inc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging Inc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Board of Radiation And Isotope Technology (BRIT) - Company Business Overview

    • Figure Board of Radiation And Isotope Technology (BRIT) Total Revenue from 2018 to 2020

    • Table Board of Radiation And Isotope Technology (BRIT) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Board of Radiation And Isotope Technology (BRIT) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Board of Radiation And Isotope Technology (BRIT)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Institute of Atomic Energy Polatom Radioisotope Centre - Company Business Overview

    • Figure Institute of Atomic Energy Polatom Radioisotope Centre Total Revenue from 2018 to 2020

    • Table Institute of Atomic Energy Polatom Radioisotope Centre Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Institute of Atomic Energy Polatom Radioisotope Centre Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Institute of Atomic Energy Polatom Radioisotope Centre

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Ntp Radioisotopes (Pty) Ltd - Company Business Overview

    • Figure Ntp Radioisotopes (Pty) Ltd Total Revenue from 2018 to 2020

    • Table Ntp Radioisotopes (Pty) Ltd Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Ntp Radioisotopes (Pty) Ltd Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Ntp Radioisotopes (Pty) Ltd

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Nordion Inc - Company Business Overview

    • Figure Nordion Inc Total Revenue from 2018 to 2020

    • Table Nordion Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Nordion Inc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Nordion Inc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Rotem Industries Ltd Inc - Company Business Overview

    • Figure Rotem Industries Ltd Inc Total Revenue from 2018 to 2020

    • Table Rotem Industries Ltd Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Rotem Industries Ltd Inc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Rotem Industries Ltd Inc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table GE Healthcare (Subsidiary Of General Electric Company) - Company Business Overview

    • Figure GE Healthcare (Subsidiary Of General Electric Company) Total Revenue from 2018 to 2020

    • Table GE Healthcare (Subsidiary Of General Electric Company) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GE Healthcare (Subsidiary Of General Electric Company) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of GE Healthcare (Subsidiary Of General Electric Company)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Isotec Inc (Sigma-Aldrich) - Company Business Overview

    • Figure Isotec Inc (Sigma-Aldrich) Total Revenue from 2018 to 2020

    • Table Isotec Inc (Sigma-Aldrich) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Isotec Inc (Sigma-Aldrich) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Isotec Inc (Sigma-Aldrich)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Taiyo Nippon Sanso Corporation - Company Business Overview

    • Figure Taiyo Nippon Sanso Corporation Total Revenue from 2018 to 2020

    • Table Taiyo Nippon Sanso Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Taiyo Nippon Sanso Corporation Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Taiyo Nippon Sanso Corporation

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Fujifilm Holdings Corporation - Company Business Overview

    • Figure Fujifilm Holdings Corporation Total Revenue from 2018 to 2020

    • Table Fujifilm Holdings Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Fujifilm Holdings Corporation Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Fujifilm Holdings Corporation

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Australian Nuclear Association And Technology Organization (ANSTO) - Company Business Overview

    • Figure Australian Nuclear Association And Technology Organization (ANSTO) Total Revenue from 2018 to 2020

    • Table Australian Nuclear Association And Technology Organization (ANSTO) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Australian Nuclear Association And Technology Organization (ANSTO) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Australian Nuclear Association And Technology Organization (ANSTO)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Cardinal Health Inc - Company Business Overview

    • Figure Cardinal Health Inc Total Revenue from 2018 to 2020

    • Table Cardinal Health Inc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cardinal Health Inc Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Cardinal Health Inc

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Siemens Healthcare (Subsidiary Of Siemens AG) - Company Business Overview

    • Figure Siemens Healthcare (Subsidiary Of Siemens AG) Total Revenue from 2018 to 2020

    • Table Siemens Healthcare (Subsidiary Of Siemens AG) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Siemens Healthcare (Subsidiary Of Siemens AG) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Siemens Healthcare (Subsidiary Of Siemens AG)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Bracco Imaging SPA - Company Business Overview

    • Figure Bracco Imaging SPA Total Revenue from 2018 to 2020

    • Table Bracco Imaging SPA Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bracco Imaging SPA Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Bracco Imaging SPA

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table IBA Group - Company Business Overview

    • Figure IBA Group Total Revenue from 2018 to 2020

    • Table IBA Group Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure IBA Group Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Eczacibasi-Monrol - Company Business Overview

    • Figure Eczacibasi-Monrol Total Revenue from 2018 to 2020

    • Table Eczacibasi-Monrol Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eczacibasi-Monrol Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Eczacibasi-Monrol

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Institute Of Radioelement (IRE) - Company Business Overview

    • Figure Institute Of Radioelement (IRE) Total Revenue from 2018 to 2020

    • Table Institute Of Radioelement (IRE) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Institute Of Radioelement (IRE) Sales and Growth Rate Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Institute Of Radioelement (IRE)

    • Table Radiopharmaceuticals in Nuclear Medicine Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Types (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Diagnostic Radiopharmaceuticals 2016-2021

    • Figure Global Revenue and Growth Rate of Therapy Radiopharmaceuticals 2016-2021

    • Figure Global Revenue and Growth Rate of Enriched Stable Isotopes 2016-2021

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Types (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Diagnostic Radiopharmaceuticals 2016-2021

    • Figure Global Sales and Growth Rate of Therapy Radiopharmaceuticals 2016-2021

    • Figure Global Sales and Growth Rate of Enriched Stable Isotopes 2016-2021

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Types (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Types (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Types (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Types (Forecast)

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Radiopharmaceuticals in Nuclear Medicine

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Application (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Diagnostic Application 2016-2021

    • Figure Global Revenue and Growth Rate of Therapeutic Application 2016-2021

    • Figure Global Revenue and Growth Rate of Research 2016-2021

    • Figure Global Revenue and Growth Rate of Pharmaceutical 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Application (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Diagnostic Application 2016-2021

    • Figure Global Sales and Growth Rate of Therapeutic Application 2016-2021

    • Figure Global Sales and Growth Rate of Research 2016-2021

    • Figure Global Sales and Growth Rate of Pharmaceutical 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Application (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Application (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Application (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Application (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Geography (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Geography (Historical)

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Geography in 2020

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Geography (Historical)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Geography (Historical)

    • Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Geography in 2020

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Geography (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Revenue Market Share by Geography (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Geography (Forecast)

    • Table Global Radiopharmaceuticals in Nuclear Medicine Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure USA Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure USA Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table North America Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure France Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure France Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table Europe Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure China Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure China Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure India Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure India Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table Asia Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table South America Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table Middle East Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table Africa Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Australia Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Radiopharmaceuticals in Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Value by Types from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Value by Application from 2016 to 2026

    • Table Oceania Radiopharmaceuticals in Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Radiopharmaceuticals in Nuclear Medicine with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US